Ha Jang-Woo, Ahn Sung-Soo, Song Jason-Jungsik, Park Yong-Beom, Lee Sang-Won
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
J Clin Med. 2023 Jun 20;12(12):4170. doi: 10.3390/jcm12124170.
Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The present study included 283 patients with AAV. The variables at AAV diagnosis such as demographic data, AAV-specific data including the Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and laboratory data including ANCA, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were collected. The number of deceased patients during the follow-up duration based on all-cause mortality was counted. The median age of the 283 AAV patients was 60 years, and 35.7% were men. ANCAs were detected in 228 patients, and the median TGF was 2.9. A total of 39 patients (13.8%) died within a median follow-up duration of 46.9 months. TGF at AAV diagnosis was significantly correlated with ESR and CRP rather than AAV activity. Patients with ANCA positivity exhibited a significantly higher median TGF at AAV diagnosis than those without. Patients with TGF ≥ 3.1 g/dL at AAV diagnosis exhibited a significantly lower cumulative survival rate than those without. Furthermore, in the multivariable Cox hazards model analysis, TGF ≥ 3.1 g/dL (hazard ratio 2.611) was independently associated with all-cause mortality, along with age, male sex, and body mass index. The present study is the first to demonstrate that TGF at AAV diagnosis can forecast all-cause mortality during the disease course in AAV patients.
总球蛋白分数(TGF)通过从血清总蛋白水平中减去血清白蛋白水平来计算。本研究探讨了抗中性粒细胞胞浆抗体(ANCA)相关血管炎(AAV)患者诊断时的TGF是否能预测疾病过程中的全因死亡率。本研究纳入了283例AAV患者。收集了AAV诊断时的变量,如人口统计学数据、AAV特异性数据(包括伯明翰血管炎活动评分(BVAS)、五因素评分(FFS))以及实验室数据(包括ANCA、红细胞沉降率(ESR)和C反应蛋白(CRP))。统计了基于全因死亡率的随访期间死亡患者的数量。283例AAV患者的中位年龄为60岁,男性占35.7%。228例患者检测到ANCA,中位TGF为2.9。在中位随访46.9个月期间,共有39例患者(13.8%)死亡。AAV诊断时的TGF与ESR和CRP显著相关,而非与AAV活动相关。ANCA阳性患者在AAV诊断时的中位TGF显著高于阴性患者。AAV诊断时TGF≥3.1 g/dL的患者累积生存率显著低于未达到该水平的患者。此外,在多变量Cox风险模型分析中,TGF≥3.1 g/dL(风险比2.611)与全因死亡率独立相关,同时还与年龄、男性性别和体重指数有关。本研究首次表明,AAV诊断时的TGF可预测AAV患者疾病过程中的全因死亡率。